DETAILS, FICTION AND NEMBUTAL ORAL MED SYRINGE

pentobarbital will decrease the level or influence of pitolisant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Intently. Pitolisant exposure is lessened by 50% if coadministered with strong CYP3A4 inducers.pentobarbital will lessen the extent or outcome of clarithromycin by impacting hepatic/intestinal enzyme CYP3